The "series of academic conferences on immune diseases and the first, second and third phases of convergence · multidisciplinary medical diagnosis and treatment exchanges" were successfully held online on September 17, September 24 and September 29, 2025. This series of academic conferences aims to build a professional, standardized and innovative high-level academic exchange platform for medical staff in immune diseases and related fields, and promote the in-depth development of clinical research in various disease fields and the significant improvement of clinical diagnosis and treatment level through the collision and integration of multiple disciplines. The conference has always adhered to the core purpose of "focusing on clinical practice, highlighting practicality, keeping abreast of the frontier, and focusing on hot spots", focused on the key issues of disease diagnosis and treatment in various specialties, and carefully set up rich links such as interpretation of Frontier guidelines, sharing of typical cases, and exchange of clinical experience, to ensure that the content of the conference has both academic height and practical value.

The conference covers a wide range of subjects and will cover a wide range of disciplines, including Cardiology, Nephrology, respiratory medicine, endocrinology, neurology, dermatology, rheumatology and immunology, hematology and other disciplines closely related to immune diseases. The conference will further discuss the latest diagnosis and treatment plan, clinical pathway optimization and frontier research progress for a variety of common immune related diseases and frequently occurring diseases, presenting a multidisciplinary academic feast for participants.

The diagnosis and treatment of immune diseases involves multi-system and multi-disciplinary collaboration. The holding of this series of academic conferences will effectively promote academic exchanges and technical cooperation among various disciplines, help medical staff timely grasp the cutting-edge trends of the industry, update the diagnosis and treatment concept, and improve clinical skills. The convening of this meeting will further condense the wisdom of the industry and contribute to the standardized development and discipline construction of the diagnosis and treatment of immune diseases in China.